Brain cancers are some of the hardest to treat. The five-year survival rate for patients with glioblastoma is only about 5% after diagnosis. Tackling this and other deadly brain cancers isn’t a one-person job; collaboration is key. What better place to get those conversations going than Cold Spring Harbor Laboratory (CSHL)?
For more than a century, CSHL has been a hub for cutting-edge biological research and education. On July 17, 2025, the CSHL Meetings & Courses Program added another first to an already impressive list with its inaugural meeting on “Advancements in Brain Tumor Research & Therapy.” The meeting brings together leading researchers and clinicians to discuss new breakthroughs and discoveries that may lead to more effective and targeted treatment strategies for these deadly cancers.
“CSHL was really the perfect place to hold this inaugural meeting because of the power of the Meetings & Courses Program,” CSHL Professor Alea Mills says. “We’re able to bring people together from all over the globe to really tackle this problem of brain cancer. Whether you’re an undergraduate, a grad student, a postdoc, a Nobel laureate—you’re meeting and interacting with such a diverse group of people. It sparks new ideas, new collaborations. It’s really fantastic.”
Mills organized the meeting alongside Eric Holland (Fred Hutchinson Cancer Center), Sadhan Majumder (MD Anderson Cancer Center), and Patrick Wen (Dana-Farber Cancer Institute). “I’m really honored to be working alongside such esteemed colleagues on this,” Mills says. Forty-three speakers are scheduled to present their work on a variety of topics including cancer genetics, immunotherapy, and the clinical aspects of brain tumors.
Written by: Nick Wurm, Communications Specialist | wurm@cshl.edu | 516-367-5940